Your browser doesn't support javascript.
loading
Phase 1 study of the safety, pharmacokinetics, and preliminary efficacy of CA102N as monotherapy and in combination with trifluridine-tipiracil in patients with locally advanced or metastatic solid tumors.
Pant, Shubham; Dragovich, Tomislav; Lieu, Christopher; Jimeno, Antonio; Kundranda, Madappa; Menter, David; Tchaparian, Eskouhie; Chen, Yuchih C; Kopetz, Scott.
Afiliação
  • Pant S; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe BLVD, Houston, TX, 77030, USA. spant@mdanderson.org.
  • Dragovich T; Division of Cancer Medicine, Banner MD Anderson Cancer Center, Gilbert, AZ, USA.
  • Lieu C; Division of Medical Oncology, University of Colorado Denver Anschutz Medical Campus and University of Colorado Cancer Center, Aurora, CO, USA.
  • Jimeno A; Division of Medical Oncology, University of Colorado Denver Anschutz Medical Campus and University of Colorado Cancer Center, Aurora, CO, USA.
  • Kundranda M; Division of Cancer Medicine, Banner MD Anderson Cancer Center, Gilbert, AZ, USA.
  • Menter D; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe BLVD, Houston, TX, 77030, USA.
  • Tchaparian E; Holy Stone Healthcare Co., Ltd., Taipei, Taiwan.
  • Chen YC; Holy Stone Healthcare Co., Ltd., Taipei, Taiwan.
  • Kopetz S; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe BLVD, Houston, TX, 77030, USA.
Invest New Drugs ; 41(1): 25-34, 2023 02.
Article em En | MEDLINE | ID: mdl-36331676

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article